|
Search
Collections
Benchmarks
Upload document
MEK-inhibitors
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
A phase 2 clinical trial of regorafenib in patients with advanced pretreated melanoma (RegoMel).
Org:
Universitair Ziekenhuis Brussel,
Vrije Universiteit Brussel,
